Dawa Ltd. announces Nairobi pharmaceutical plant expansion
Leading Kenyan pharmaceutical company, Dawa Ltd., has announced that it will be committing Sh3bn (US$290m) to the construction of a new factory at its current Nairobi plant.
The investment is evidence of the company’s progress in recent years, having expanded from just 20 employees in 2004 to its current 400.
As part of the announcement, Managing Director of Dawa, Dr Ajay Patel, outlined his hopes that the expanded facility will help the company access a greater number of African markets.
“Last year we achieved a Sh2 billion turnover up from 2015’s Sh1.8 billion which informs our strategy for expansion. We also plan to enter the Tanzania market via a distribution network that we have now established,” said Dawa Ltd.’s General Manager of Sales and Marketing, Sunil Kumar, who made the announcement alongside Patel.
The pair also announced that the new factory will feature the industry’s latest machinery, allowing the company to launch a new line of new lifetstyle drugs aimed at treating Diabetic, hypertensive and cardiovascular patients.
- Sigma7’s Jeffrey Wells on the evolving threats of ransomwareProcurement & Supply Chain
- Pushing the agenda on sustainability in the medical industryProcurement & Supply Chain
- Loftware’s support of pharma & medical device sectorMedical Devices & Pharma
- How optimising the supply chain is critical for healthcareProcurement & Supply Chain